Rexulti, the first drug to relieve Alzheimer's emotions - TimesKuwait

The US Food and Drug Administration (FDA) has granted fast-track approval of the first drug aimed at relieving the emotions associated with Alzheimer’s disease. The FDA published, on its official website, a statement confirming the approval of Otsuka Pharmaceutical Company and Lundbeck, producers of oral Rexulti tablets to relieve the emotions associated with Alzheimer’s disease, […]

First FDA Approved Medication for Agitation Associated with Alzheimer's Dementia – Psychiatry Education Forum

Positive Data for First and Only Treatment Approved for Agitation in Alzheimer Dementia

REXULTI® (brexpiprazole) agitation that may happen with dementia due to Alzheimer's disease

This Antipsychotic Drug Can Now Be Used to Treat Agitation in Alzheimer's Patients

Brexpiprazole (Rexulti) Approved for Alzheimer's Agitation

FDA approves Rexulti for agitation tied to Alzheimer's dementia, Daily therapy is first to be approved for this use in US

REXULTI® (brexpiprazole) Agitation associated with dementia due to Alzheimer's disease

First FDA Approved Medication for Agitation Associated with Alzheimer's Dementia – Psychiatry Education Forum

Brexpiprazole (Rexulti) Approved for Alzheimer's Agitation

This Antipsychotic Drug Can Now Be Used to Treat Agitation in Alzheimer's Patients

US FDA approves Rexulti as first drug for agitation in Alzheimer's dementia

Drug repurposing for Alzheimer's disease: Selective serotonin reuptake inhibitors - Rao - 2020 - Alzheimer's & Dementia - Wiley Online Library

Brexpiprazole (Rexulti) Approved for Alzheimer's Agitation

Brexpiprazole (Rexulti) Approved for Alzheimer's Agitation

Otsuka, Lundbeck's Rexulti scores new Alzheimer's use